Health and medicine saw a day of stark contrasts, with a dangerous Ebola outbreak in the Democratic Republic of Congo worsened by an attack on a treatment centre, while scientists in Cambridge announced a first for heart damage repair and Boehringer and Zealand reported their obesity drug posed no heart risks in a trial.
Ebola in DRC: patients flee after attack on treatment centre
The Telegraph reported that fears are growing over Ebola spread in the Democratic Republic of Congo after patients fled an attack on a treatment centre. The incident raises the risk of further transmission.
Reported by The Telegraph
Heart damage can be repaired, Cambridge scientists find
Cambridge scientists have discovered a way to repair heart damage for the first time, according to The Telegraph. The breakthrough could change treatment for heart conditions.
Reported by The Telegraph
Obesity drug from Boehringer and Zealand shows no heart risk
Data from a trial of a Boehringer and Zealand obesity drug showed it did not raise heart risks, Reuters reported. The finding supports the drug's safety profile.
Reported by Reuters
Genetic hitchhikers keep Aspergillus infections resistant
Research from Wageningen University in Current Biology found that resistance to antifungal medicines in Aspergillus fumigatus persists because agricultural fungicides, even those with a different action, help maintain resistance genes that hitchhike together. This makes treating the fungus harder.
Reported by Phys.org - latest science and technology news stories
Checked
10 claims in this story checked against 3 sources: 3 supported.
Show each claim
- SupportedFears over Ebola spread in the DRC are growing as patients flee an attack on a treatment centre."site:telegraph.co.uk when:1d" - Google News: “Fears over Ebola spread in DRC as patients flee attack on treatment centre - The Telegraph.”
- Partly supportedA dangerous Ebola outbreak in the DRC was worsened by the attack."site:telegraph.co.uk when:1d" - Google News: “Fears over Ebola spread in DRC as patients flee attack on treatment centre - The Telegraph.”
- Not in the sourcesThe attack raises the risk of further Ebola transmission."site:telegraph.co.uk when:1d" - Google News: “Fears over Ebola spread in DRC as patients flee attack on treatment centre - The Telegraph.”
- SupportedCambridge scientists found that heart damage can be repaired for the first time."site:telegraph.co.uk when:1d" - Google News: “Heart damage can be repaired for first time, Cambridge scientists find - The Telegraph.”
- Not in the sourcesThe heart-repair breakthrough could change treatment for heart conditions."site:telegraph.co.uk when:1d" - Google News: “Heart damage can be repaired for first time, Cambridge scientists find - The Telegraph.”
- Partly supportedBoehringer and Zealand reported that their obesity drug posed no heart risks in a trial."site:reuters.com/business when:1d" - Google News: “Boehringer, Zealand's obesity drug did not raise heart risks in trial, data shows - Reuters.”
- Partly supportedThe trial showed the obesity drug posed no heart risks."site:reuters.com/business when:1d" - Google News: “Boehringer, Zealand's obesity drug did not raise heart risks in trial, data shows - Reuters.”
- Not in the sourcesResearch from Wageningen University published in Current Biology found the reported results.Phys.org - latest science and technology news stories: “Genetic hitchhikers make Aspergillus infections even harder to treat.”
- Not in the sourcesAgricultural fungicides, including ones with a different action, maintain hitchhiking resistance genes and thereby keep Aspergillus resistance to antifungal medicines persistent.Phys.org - latest science and technology news stories: “Genetic hitchhikers make Aspergillus infections even harder to treat.”
- SupportedGenetic hitchhikers make Aspergillus infections harder to treat.Phys.org - latest science and technology news stories: “Genetic hitchhikers make Aspergillus infections even harder to treat.”
